和誉-B(02256)附属与阿斯利康达成战略合作开展同类首创口服PD-L1抑制剂ABSK043联合泰瑞沙®治疗非小细胞肺癌的临床研究
Last Update:
2 7 月, 2026
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.